A detailed history of Jones Financial Companies Lllp transactions in Evotec Se stock. As of the latest transaction made, Jones Financial Companies Lllp holds 150 shares of EVO stock, worth $618. This represents 0.0% of its overall portfolio holdings.

Number of Shares
150
Previous 7,324 97.95%
Holding current value
$618
Previous $24,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 28, 2025

SELL
$3.31 - $4.71 $23,745 - $33,789
-7,174 Reduced 97.95%
150 $0
Q1 2025

May 16, 2025

BUY
$3.31 - $4.71 $24,242 - $34,496
7,324 New
7,324 $24,000

Others Institutions Holding EVO

About Evotec SE


  • Ticker EVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 353,904,992
  • Market Cap $1.46B
  • Description
  • Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare di...
More about EVO
Track This Portfolio

Track Jones Financial Companies Lllp Portfolio

Follow Jones Financial Companies Lllp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jones Financial Companies Lllp, based on Form 13F filings with the SEC.

News

Stay updated on Jones Financial Companies Lllp with notifications on news.